Chemed CHE Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 32.5%-2.6pp | 35.1%-0.1pp | 35.3%-0.6pp | 35.8%-0.1pp | |
| Operating margin | 13.4%-1.7pp | 15.1%0.0pp | 15%-1.0pp | 16.1%+0.1pp | |
| Net margin | 10.5%-1.9pp | 12.4%+0.4pp | 12%+0.3pp | 11.7%-0.9pp | |
| Returns | |||||
| Return on equity | 25.3%-1.8pp | 27.1%-1.5pp | 28.6%-6.5pp | 35.1%-0.1pp | |
| Return on invested capital | 27%-3.4pp | 30.4%+0.2pp | 30.2%-1.2pp | 31.4%-1.8pp | |
| Efficiency | |||||
| Asset turnover | 1.6×+0.1× | 1.5×0.0× | 1.5×-0.1× | 1.5×0.0× | |
| Liquidity | |||||
| Current ratio | 1.1×-0.3× | 1.4×-0.2× | 1.6×+0.7× | 0.9×+0.2× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×-0.2× | 0.3×-0.2× | |
| Net debt / EBITDA | 0.2×+0.3× | -0.1×+0.2× | -0.3×-0.7× | 0.4×-0.3× | |
| Per Share | |||||
| Book value per share | $67.73-8.1% | $73.69+1.1% | $72.89+37.8% | $52.90+35.3% | |
| Valuation | |||||
| Market capitalization | $6.04B-24.0% | $7.94B-10.1% | $8.83B+16.0% | $7.61B-4.0% | |
| Price / earnings | 22.8×-3.5× | 26.3×-6.1× | 32.4×+1.9× | 30.5×+1.0× | |
| Price / sales | 2.4×-0.9× | 3.3×-0.6× | 3.9×+0.3× | 3.6×-0.1× | |
| Price / book | 6.2×-0.9× | 7.1×-0.9× | 8×-1.6× | 9.5×-3.2× | |
| EV / EBITDA | 15.1×-3.2× | 18.4×-3.3× | 21.7×+2.4× | 19.3×-1.1× | |
| Dividend yield | 0.5%+0.2pp | 0.3%+0.1pp | 0.3%0.0pp | 0.3%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Chemed's profit margins?
- Chemed (CHE) runs a 32.4% gross margin and a 12.9% operating margin, with a 10.2% net margin.
- Where do Chemed's ratios come from?
- Every ratio is computed from Chemed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
